MedTrace Logo

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

NCT07193823 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2025-09-26

No results posted yet for this study

Summary

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction.

For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

Conditions

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Yesim Akkoc, M.D., Prof · Ege University Faculty of Medicine, Department of Physical Medicine and Rehabilitation

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-16
Primary Completion
2025-10-31
Completion
2025-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07193823 on ClinicalTrials.gov